Cameron HeroldFounder of the COO Alliance & Invest In Your Leaders Training

Not All Psychedelics Are Safe for Everyone | Steven Huang

25 Nov 2025 · 1 min

Watch on YouTube

0:57

Short excerpt from a YouTube interview discussing psychedelics. Speakers state that most psychedelic use occurs outside clinical settings and that many different psychedelics/combinations are used for personal and professional development. Cameron Herold recounts his son's severe clinical anxiety and depression (previous bipolar II diagnosis since removed), hospitalization, and clinicians' views that MDMA and ketamine therapy might help while psilocybin could pose risks (potentially triggering symptoms).

Chapters

99% of people use psychedelics outside of that medical clinical context, and they're using it for personal growth, professional leadership, development, all sorts of ways. And because there's different psychedelics, there's almost like a. Almost an infinite number of combinations of psychedelics for different purposes.
My son has struggled with clinical anxiety, clinical depression. At one point had a bipolar 2 diagnosis that they've since removed. But his depression and anxiety and even some OCD was so severe that he failed out of university because of it. It was crippling. At one point, he actually was hospitalized for about eight days. We've had a couple of different physicians have said that MDMA therapy would be huge for him, as would potentially ketamine therapy, but they were worried about psilocybin therapy, that it could possibly trigger something. So it's interesting to understand how these different modalities can serve different purposes. For sure.